Insider · CIK 0002034679

Raben David

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0002034679

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+575K sh	—	—	575,000
2026-04-27	BCAXBicara Therapeutics Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+5,500 sh	$3.79	+$20.8K	60,786
2026-04-27	BCAXBicara Therapeutics Inc.S Sale	Chief Medical Officer	SSale	−5,500 sh	$22.88	−$126K	55,286
2026-04-27	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−5,500 sh	—	—	41,913
2026-03-25	BCAXBicara Therapeutics Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+5,500 sh	$3.79	+$20.8K	60,786
2026-03-25	BCAXBicara Therapeutics Inc.S Sale	Chief Medical Officer	SSale	−5,500 sh	$18.95	−$104K	55,286
2026-03-25	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−5,500 sh	—	—	47,413
2026-03-04	BCAXBicara Therapeutics Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+16.3K sh	$3.79	+$61.8K	71,586
2026-03-04	BCAXBicara Therapeutics Inc.S Sale	Chief Medical Officer	SSale	−16.3K sh	$18.52	−$302K	55,286
2026-03-04	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−16.3K sh	—	—	52,913
2026-03-03	BCAXBicara Therapeutics Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+200 sh	$3.79	+$757.96	55,486
2026-03-03	BCAXBicara Therapeutics Inc.S Sale	Chief Medical Officer	SSale	−200 sh	$18.45	−$3,690	55,286
2026-03-03	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−200 sh	—	—	69,213
2026-02-02	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+100K sh	—	—	100,000
2025-12-26	BCAXBicara Therapeutics Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+19.8K sh	$3.79	+$75K	55,286
2025-12-26	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−19.8K sh	—	—	98,987
2025-11-25	BCAXBicara Therapeutics Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,594 sh	$3.79	+$17.4K	40,091
2025-11-25	BCAXBicara Therapeutics Inc.S Sale	Chief Medical Officer	SSale	−4,594 sh	$18.84	−$86.6K	35,497
2025-11-25	BCAXBicara Therapeutics Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+906 sh	$3.79	+$3,433.559	36,403
2025-11-25	BCAXBicara Therapeutics Inc.S Sale	Chief Medical Officer	SSale	−906 sh	$18.84	−$17.1K	35,497
2025-11-25	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,594 sh	—	—	118,776
2025-11-25	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−906 sh	—	—	69,413
2025-11-24	BCAXBicara Therapeutics Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+5,500 sh	$3.79	+$20.8K	40,997
2025-11-24	BCAXBicara Therapeutics Inc.S Sale	Chief Medical Officer	SSale	−5,500 sh	$18.45	−$101K	35,497
2025-11-24	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−5,500 sh	—	—	123,370
2025-10-09	BCAXBicara Therapeutics Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+22K sh	$3.79	+$83.4K	57,497
2025-10-09	BCAXBicara Therapeutics Inc.S Sale	Chief Medical Officer	SSale	−22K sh	$18.45	−$406K	35,497
2025-10-09	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−22K sh	—	—	128,870

Recent filings

Accepted (ET)
Oct 24
Raben David0001746473-26-000117
SEC(opens sec.gov)
Apr 284
Raben David0001628280-26-028054
SEC(opens sec.gov)
Mar 264
Raben David0001628280-26-021543
SEC(opens sec.gov)
Mar 54
Raben David0001628280-26-015419
SEC(opens sec.gov)
Feb 44
Raben David0001628280-26-005479
SEC(opens sec.gov)
Dec 294
Raben David0001628280-25-059035
SEC(opens sec.gov)
Nov 254
Raben David0002034679-25-000006
SEC(opens sec.gov)

Companies

Address

C/O PLIANT THERAPEUTICS, INC. 331 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080